Outside of journalism, I like to explore personal stories through creative writing. My memoir essay, “A refugee daughter’s pilgrimage,” is published in the latest issue of the Australian literary magazine Meanjin.
#memoir #lifewriting #refugees @meanjin.bsky.social
meanjin.com.au/memoir/a-ref...
My colleagues and I wrote about how London’s bid to revive its shrinking stock market has faced a series of setbacks in recent weeks, with companies shifting listings and IPO plans from the market.
#markets #uk #stocks #stockmarket #stocklistings #ipos
www.bloomberg.com/news/article...
I teamed up with a colleague to write about the divergence between two Swiss chocolate stocks amid soaring cocoa prices. Lindt shares are hovering near a record high, while Barry Callebaut fell to a 2011 low last month.
#markets #stocks #swiss #chocolate
www.bloomberg.com/news/article...
ICYMI: I recently wrote about a clutch of volcanic islands in the Indian Ocean being the real-life battleground between a virus that could ignite a pandemic — chikungunya — and the first vaccine to address it.
#health #vaccines #chikungunya #prognosisnewsletter
www.bloomberg.com/news/newslet...
ICYMI: I wrote about a blood test that could potentially speed up the time it takes for endometriosis to be diagnosed, for Bloomberg’s Prognosis newsletter last month.
#health #womenshealth #endometriosis #bloodtest #prognosisnewsletter
www.bloomberg.com/news/newslet...
Breaking News: A baby with a rare disorder made medical history by receiving the first custom gene-editing treatment. The technique used has the potential to help people with thousands of other uncommon genetic diseases. nyti.ms/4j49xBy
My story published today looks at how hearing aids have been spared from US President Donald Trump’s trade war, with Europe’s dominance in this sector set to continue.
#hearingaids #tariffs #trump #europe #denmark #siliconvalleyofsound
www.bloomberg.com/news/article...
ICYMI: I wrote about plant-based burgers for Bloomberg’s Prognosis newsletter last month.
#health #burgers #nutrition #plantbased #hrv #longcovid #prognosisnewsletter
www.bloomberg.com/news/newslet...
New from @davidarmstrongx.bsky.social:
When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.
John Green has written a new, already best-selling nonfiction book on tuberculosis that asks a pointed question: Why does a fully curable disease still kill more than a million people a year? Read or listen to our conversation with the author. nyti.ms/4l6WykQ
After the Trump administration abruptly cut $400 million in funding to Columbia University, dozens of medical and scientific studies are ending or at risk of ending, leaving researchers scrambling to find alternative funding.
Five years after the WHO declared the Covid-19 pandemic, scientists are getting a clearer picture of how the virus can lead to long-term, sometimes invisible changes.
NEW: Vaccines. Fluoride. Autism.
Communications involving these and 20 other “controversial, high profile, or sensitive” topics will get extra scrutiny under Health Secretary Robert F. Kennedy Jr.
By @anniewaldman.bsky.social and @lisalsong.bsky.social
My latest piece for Bloomberg’s Prognosis newsletter is about a biotech company turning to llama antibodies in the search for new obesity drugs.
#health #biotech #obesitydrugs #llamas #prognosisnewsletter
www.bloomberg.com/news/newslet...
Really proud of this piece. Grateful to Avalyn, Rowan and Sarah for sharing their stories. It's a national scandal that long Covid patients have been forgotten by the government, employers & society at large. The least we can do is keep talking about them
www.theguardian.com/society/2025...
BREAKING: The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a move that could complicate efforts to produce flu shots in time for the upcoming season. 1/2
www.bloomberg.com/news/article...
SCOOP > The Trump administration is weighing pulling Moderna's contract to create bird flu shots, part of a bigger effort to question spending on messenger RNA-based vaccines
Madison Muller, @rileyraygriffin.bsky.social and @ikeswetlitz.bsky.social
www.bloomberg.com/news/article...
Asparagus tart with Gruyère cheese. #homecooking #sundaylunch
Novo Nordisk shares had their worst week this year, after a Super Bowl advertisement touting copycat products underscored the challenge to its weight-loss blockbuster drug. Here’s my story with Naomi Kresge via @bloomberg.com
#markets #shares #weightlossdrugs
www.bloomberg.com/news/article...
Why a food dye that’s getting banned in the US is staying in cocktail cherries in the UK — here’s my latest piece for Bloomberg’s Prognosis newsletter.
#health #food #artificialfooddyes #cocktailcherries #prognosisnewsletter
www.bloomberg.com/news/newslet...
The Trump administration's stop-work order on USAID left thousands of volunteers around the world w/ experimental drugs + medical devices in their bodies – cut off from care by researchers running clinical trials, in violation of the fundamental principles of research www.nytimes.com/2025/02/06/h...
Drugmaker Novo Nordisk will report earnings next week, but there’s still a long way to go to claw back the stock declines of the past six months. Here’s my story published today via @bloomberg.com
#markets #shares #pharma
www.bloomberg.com/news/article...
My story published today looks at how hearing-aid makers have become one of the stock market’s less likely artificial intelligence plays. Via @bloomberg.com
#markets #stocks #hearingaids #ai
www.bloomberg.com/news/article...
Danish drugmaker Novo Nordisk lost its crown as Europe’s most valuable listed company on Friday, after its market capitalisation fell below that of French luxury-goods maker LVMH. Here’s my story with Kit Rees via @bloomberg.com
#markets #stocks
www.bloomberg.com/news/article...
My latest article published today is about Alzheimer’s drugs and the developments to watch this year, as investors eye the next obesity-like market opportunity. Via @bloomberg.com
#markets #stocks #alzheimersdrugs
www.bloomberg.com/news/article...
Scientists are combatting mosquito-borne sicknesses by infecting the insects with bacteria to fight the diseases they carry.
I wrote a piece about how I recently got reinfected with Covid (a nightmare prospect for anyone with long Covid) and the light sensitivity issues that caused.
#longcovid #prognosisnewsletter #covidreinfection #photophobia #lightsensitivity
www.bloomberg.com/news/newslet...
long covid isn't just stopping people from working, exercising, socialising, living independently. it's also snuffing out patients' dreams of having children, and complicating pregnancy for those who are able to conceive www.abc.net.au/news/2024-12...
2024 has been a volatile year for investors in weight-loss drug developers. My latest article with Angel Adegbesan delves into what happened this year and what to watch in 2025. Via @bloomberg.com
#stocks #markets #investing #obesitydrugs #pharma
www.bloomberg.com/news/article...